share_log

Stocks of the Hour: Nimy Resources, New Age Exploration, Immutep

Stocks of the Hour: Nimy Resources, New Age Exploration, Immutep

當下股票:Nimy Resources、新時代探索、Immutep
sharecafe ·  04/17 21:50

Nimy Resources (ASX:NIM) advises that drilling at Block 3 within its Mons project in WA has returned intersections of elevated copper, gold, silver mineralisation in massive sulphides plus high-grade gallium and rare earth oxide mineralisation. A gradient array-induced polarisation survey is planned over the Block 3 Prospect targeting copper, gold, and silver hosted by sulphide mineralisation. Shares are trading 86.36 per cent higher at 8.2 cents.

Nimy Resources (ASX: NIM) 表示,其位於西澳大利亞州蒙斯項目的3號區塊的鑽探已經返回了塊狀硫化物中高位的銅、金、銀礦化以及高品位鎵和稀土氧化物礦化的交叉點。計劃對3號區塊進行梯度陣列誘導的極化調查,目標是硫化物礦化所含的銅、金和銀。股價上漲86.36%,至8.2美分。

New Age Exploration (ASX:NAE) has commenced exploration at the Wagyu Gold Project Central Pilbara, WA. The progarm of work for air core drilling was submitted in March, with a plan to follow up with RC drilling. Shares are trading 33.33 per cent higher at 0.4 cents.

新時代勘探(澳大利亞證券交易所股票代碼:NAE)已開始在華盛頓州皮爾巴拉中心和牛黃金項目進行勘探。空心鑽探工作計劃已於3月提交,並計劃繼續進行RC鑽探。股價上漲33.33%,至0.4美分。

Immutep (ASX:IMM) has appointed the Centre for Human Drug Research as the leading research institute to conduct a first-in-human Phase I study of IMP761. The trial is expected to begin mid-CY 2024. Shares are trading 0.71 per cent lower at 34.75 cents.

Immutep(澳大利亞證券交易所股票代碼:IMM)已任命人類藥物研究中心作爲對 IMP761 進行首次人體 I 期研究的領先研究機構。該試驗預計將於2024年中期開始。股價下跌0.71%,至34.75美分。

1x1.png?futu_img_keep_extra_domain=1

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論